Hi Gus, some valid points but my limited research suggests two things:
1. The US is still the largest single market for patients with CF.
2. If there was a big market for CF in China, they'd rip off the drug (it's only powdered sugar) and take their chances PXS would never have any success suing them.
US approval is still the approval PXS needs for Bronchitol (although Bronchiectasis may well exclipse this in time)..
- Forums
- ASX - By Stock
- SNT
- response letter
response letter, page-12
-
- There are more pages in this discussion • 26 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SNT (ASX) to my watchlist
|
|||||
Last
4.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $47.76M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 5 | 4.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.0¢ | 99162 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 5 | 0.040 |
1 | 99807 | 0.039 |
2 | 500000 | 0.038 |
1 | 5000 | 0.037 |
2 | 295193 | 0.036 |
Price($) | Vol. | No. |
---|---|---|
0.040 | 99162 | 1 |
0.041 | 14300 | 1 |
0.043 | 5769 | 1 |
0.045 | 133423 | 2 |
0.046 | 94076 | 3 |
Last trade - 16.12pm 29/07/2024 (20 minute delay) ? |
Featured News
SNT (ASX) Chart |
Day chart unavailable